Filing Details

Accession Number:
0001641172-25-014569
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2025-06-10 17:25:23
Reporting Period:
2025-06-04
Filing Date:
2025-06-10
Accepted Time:
2025-06-10 17:25:23
Original Submission Date:
2025-06-04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1847345 Aspire Biopharma Holdings Inc. ASBP () 4/A
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1616905 G. Donald Fell 194 Candelaro Drive, #233
Humacao PR 00791
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Acquisiton 2025-06-04 9,500 $0.39 9,500 No 4 P Direct
Common Stock, Par Value $0.0001 Acquisiton 2025-06-05 10,500 $0.39 20,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct